Does vitamin B6 help with heart palpitations during perimenopause?

Vitamin B6 has an indirect but biologically plausible connection to heart palpitations during perimenopause. There is no direct clinical trial showing that B6 supplementation reduces palpitation frequency in perimenopausal women, so honesty about the evidence is important here. What the research does show is that B6 influences several systems that can contribute to the palpitation experience, and addressing B6 status as part of a broader nutritional foundation is a reasonable step.

Heart palpitations during perimenopause are common and usually benign. The primary driver is fluctuating estrogen. Estrogen influences the electrical conduction system of the heart, the sensitivity of cardiac adrenergic receptors, and the balance of the autonomic nervous system between sympathetic (activating) and parasympathetic (calming) tone. As estrogen levels become erratic, women often notice palpitations, particularly during hot flashes, when adrenaline surges, and in the luteal phase of the cycle when progesterone is also shifting.

B6 enters this picture through its role in the nervous system and neurotransmitter balance. B6 is essential for synthesizing GABA, the primary inhibitory neurotransmitter in the central nervous system. GABA reduces neural excitability and supports parasympathetic tone. When GABA synthesis is suboptimal due to inadequate B6, the balance can tip toward sympathetic dominance: higher resting heart rate, more pronounced responses to stress, and a lower threshold for palpitations. Anxiety also increases sympathetic activation directly, and B6 supports serotonin and dopamine production as well, both of which affect anxiety levels and mood stability.

A study by Mahdavi and colleagues in 2019 found that B6 supplementation reduced anxiety through GABA-related mechanisms. Since anxiety is a major amplifier of palpitation awareness, even in women whose palpitation rate is not dramatically elevated, reducing anxiety can reduce the distress associated with palpitations and potentially reduce their perceived frequency. This is an indirect mechanism but a clinically meaningful one.

B6 also participates in homocysteine metabolism alongside B12 and folate. Elevated homocysteine has been associated with endothelial dysfunction and cardiovascular risk factors, though it is not a direct cause of benign perimenopausal palpitations. Maintaining healthy homocysteine levels through adequate B6, B12, and folate intake is sound cardiovascular practice regardless of its specific effect on palpitations.

Dietary sources of B6 include poultry, fish, chickpeas, potatoes, sunflower seeds, and fortified cereals. Most women eating varied diets have reasonable baseline intake, but deficiency can occur with restricted eating, inflammatory bowel conditions, or certain medication interactions. Plasma pyridoxal phosphate (PLP) is the most accurate way to assess functional status.

Drug interactions are an important consideration. B6 may reduce the effectiveness of levodopa (used for Parkinson's disease) and may interact with anticonvulsant medications including phenobarbital and phenytoin. If you take either of these drug classes, discuss B6 supplementation with your provider before starting. Some cardiac medications may also be relevant to discuss, particularly if you are being treated for an underlying arrhythmia.

Studies investigating B6 for hormone-related and anxiety-related symptoms have used doses in the range of 50 to 100 mg daily. Your healthcare provider can help determine the right dose for your situation. A key safety point: B6 at chronically high doses above approximately 200 mg per day can cause peripheral neuropathy, presenting as tingling, numbness, or balance problems. This is reversible in most cases when supplementation is reduced, but it is a genuine risk. Check labels across multivitamins, B-complex products, and individual supplements to avoid unintentional high intake from combined sources.

For palpitations that are primarily anxiety-driven, addressing magnesium status alongside B6 may be helpful. Magnesium deficiency is common during perimenopause and is associated with heightened sympathetic tone, muscle tension, and palpitation awareness. The combination of B6 and magnesium has evidence for reducing PMS-related symptoms, and the same biological logic applies during perimenopause.

Tracking how your symptoms shift over time, using a tool like PeriPlan, can help you spot patterns in palpitation timing relative to your cycle phase, sleep quality, stress, and caffeine intake. This information helps distinguish hormonally-driven palpitations from anxiety-driven ones from nutritionally-influenced ones, and gives your provider more useful data.

When to talk to your doctor: Any new palpitations should be discussed with a provider. Palpitations with chest pain, pressure, or tightness require immediate emergency evaluation. Palpitations with significant shortness of breath, fainting or near-fainting, or a sustained rapid heart rate above roughly 150 beats per minute that does not resolve within a few minutes need prompt assessment. Even if palpitations feel clearly hormonal or anxiety-related, a baseline cardiac evaluation including an ECG is appropriate to rule out structural or electrical causes before relying on lifestyle or supplement approaches.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.